Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients

NCT02812992 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma Pancreas

Interventions

DRUG: Nab-paclitaxel
DRUG: Gemcitabine
OTHER: Best Supportive Care

Sponsor

AIO-Studien-gGmbH